Grand Brilliance Group Holdings Ltd is an investment holding company primarily engaged in the supply of medical devices. The Company also provides medical device solutions, including market trend analysis, medical device procurement, after-sales service, technical support and training, medical device rental services, and quality assurance. The Company primarily sells medical device products, including medical consumables, medical equipment, and medical devices. In addition, the Company also offers repair services and medical device rental services.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
26-09-25	HK$0.1550	+1.31%	820,000
26-09-24	HK$0.1530	+2.68%	230,000
26-09-23	HK$0.1490	-3.87%	10,000
26-09-22	HK$0.1550	0.00%	80,000
26-09-21	HK$0.1550	0.00%	0

Delayed Quote Hong Kong S.E.

More quotes

Market Closed - Hong Kong S.E. 04:08:14 2026-09-25 EDT			5-day change	1st Jan Change
0.1550 ^HKD	+1.31%		0.00%	+18.32%

06-26	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
06-26	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI

Market Cap	124M 15.81M 13.87M 13.1M 11.94M 22.35M 1.52B 22.51M 157M 60.72M 774M 59.35M 58.07M 2.49B	P/E 2025	9.13x	P/E 2026	12.5x
Enterprise Value	68.65M 8.75M 7.68M 7.25M 6.61M 12.37M 839M 12.46M 86.79M 33.62M 429M 32.86M 32.15M 1.38B	EV / Sales 2025	0.25x	EV / Sales 2026	0.49x
Free-Float	26.9%	Yield 2025	2.31%	Yield 2026	1.91%

06-26	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
06-26	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
11-21	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI
25-06-20	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
25-06-20	Grand Brilliance Group Holdings Limited Announces Interim Dividend for the Financial Year End 31 March 2025, Payable on August 11, 2025	CI
25-05-27	Grand Brilliance Group Holdings Limited Announces Board and Committee Changes, Effective 1 June 2025	CI
25-03-14	Grand Brilliance Group Holdings Limited Announces Resignation of Mr. Mui Wai Sum as Independent Non-Executive Director and Chairman and Member of the Audit Committee and Member of Remuneration Committee	CI
24-11-08	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2024	CI
24-06-28	Grand Brilliance Group Holdings Limited Declares Interim Dividend for the Year Ended 31 March 2024, Payable on or Before 12 August 2024	CI
24-06-28	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
23-11-13	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI
23-09-15	Grand Brilliance Group Holdings Limited Announces Board Changes, Effective September 18, 2023	CI
23-08-11	Grand Brilliance Group Holdings Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	CI

1 day	+1.31%
Current month	+6.16%
1 month	+8.39%
3 months	+10.71%
6 months	+18.32%
Current year	+18.32%

Grand Brilliance Group Holdings Limited Stock

Stocks

8372

KYG4136R1020

Medical Equipment, Supplies & Distribution

Valuation: Grand Brilliance Group Holdings Limited

Chart: Grand Brilliance Group Holdings Limited

Latest news: Grand Brilliance Group Holdings Limited

Quotes and Performance

Price Extremes

Managers and Directors: Grand Brilliance Group Holdings Limited

Medical Equipment Wholesale

Financials

Company Profile

Quotes

1 week	0.15	0.18
1 month	0.14	0.18
Current year	0.12	0.18
1 year	0.1	0.18
3 years	0.07	0.18
5 years	0.06	0.18
10 years	0.06	0.57

Manager	Title	Age	Since
Bik Kwan Wong CEO	Chief Executive Officer	57	2018-02-28
Chong Chi Cheung DFI	Director of Finance/CFO	48	-
Ka Man Lee SEC	Corporate Secretary	52	2019-09-23

Director	Title	Age	Since
Bik Kwan Wong CHM	Chairman	57	2018-02-28
Yin Shun Miu BRD	Director/Board Member	59	2017-09-17
Man Wai Chiu BRD	Director/Board Member	57	2017-09-17

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GRAND BRILLIANCE GROUP HOLDINGS LIMITED	+1.31%	0.00%	+42.20%	+103.95%	15.81M
HENRY SCHEIN, INC.	+0.98%	+1.80%	+31.58%	+17.11%	9.63B
SHIP HEALTHCARE HOLDINGS, INC.	+1.37%	+0.67%	+7.56%	+10.39%	1.43B
SHANGHAI C&D INNOSTIC MEDICAL TECHNOLOGY GROUP CO., LTD.	-0.71%	-1.45%	-46.09%	-	1.24B
AS ONE CORPORATION	+1.13%	-0.31%	-2.75%	-8.31%	1.15B
COWEALTH MEDICAL CHINA CO.,LTD.	+10.02%	+9.46%	+129.34%	+76.69%	885M
GKHT MEDICAL TECHNOLOGY CO., LTD.	-0.69%	+1.78%	-20.04%	-56.38%	597M
NIPPON CARE SUPPLY CO., LTD.	-0.34%	-1.45%	+99.50%	+157.75%	435M
EXCELSIOR MEDICAL CO., LTD.	-0.42%	-1.10%	-15.41%	-11.23%	426M
PT MULTI MEDIKA INTERNASIONAL TBK	+0.56%	+3.49%	+354.08%	+862.16%	238M
Average	+1.32%	+1.17%	+58.00%	+128.01%	1.6B
Weighted average by Cap.	+1.25%	+1.56%	+29.86%	+32.10%

	2025	2026
Net sales	94.45M 12.04M 10.57M 9.98M 9.09M 17.02M 1.15B 17.14M 119M 46.25M 590M 45.21M 44.23M 1.89B	101M 12.84M 11.27M 10.64M 9.7M 18.15M 1.23B 18.28M 127M 49.32M 629M 48.21M 47.16M 2.02B
Net income	9.46M 1.21M 1.06M 999K 911K 1.71M 116M 1.72M 11.96M 4.63M 59.05M 4.53M 4.43M 190M	8.41M 1.07M 941K 889K 810K 1.52M 103M 1.53M 10.64M 4.12M 52.52M 4.03M 3.94M 169M
Net Debt	-62.36M -7.95M -6.98M -6.59M -6M -11.24M -762M -11.32M -78.85M -30.54M -389M -29.85M -29.21M -1.25B	-55.35M -7.06M -6.19M -5.85M -5.33M -9.98M -676M -10.05M -69.98M -27.11M -346M -26.49M -25.92M -1.11B